Ting A. Wang Weinman, MD, PhD

Professional Background

Ting Wang-Weinman, M.D., Ph.D. obtained her M.D. degree from Peking University Health and Science Center (formerly known as Beijing Medical University) in China. After completing her MD she moved to the US where she obtained her Ph.D. in Biomedical Science at the University of Texas Medical Branch. She subsequently did Internal Medicine and Dermatology Residency training at KU Medical Center in Kansas City. She is a Board Certified Dermatologist who is skilled in General Dermatology and has an interest in skin cancer, skin diseases in immunosuppressed patients, and other systemic diseases with dermatological manifestations.

• MD, Clinical Medicine, Beijing Medical University (now Peking University Health Science Center), Beijing, China
• PhD, Cell Biology, Univ of Texas Medical Branch, Galveston, Texas
• Residency, Dermatology, University of Kansas Medical Center, Kansas City, KS
• Residency, Internal Medicine, University of Kansas Medical Center, Kansas City, KS
• Internship, Internal Medicine, University of Kansas Medical Center, Kansas City, KS
• Post Doctoral Fellowship, Cell Biology, University of Texas Medical Branch, Galveston, TX

• American Board of Dermatology Certification, American Board of Dermatology
• KS medical license, Kansas State Board of Healing Arts

• Association of Professors of Dermatology, Fellow, 2022 - Present
• American Academy of Dermatology, Member, 2015 - Present

---

Research

Overview

I am engaged in clinical research and am the co-investigator of a multicenter NIH funded study of vasculitis and skin disease. In this clinical trial, I have been working closely with KU site PI, Dr. Springer in the past and Dr. Bath currently. Patients with cutaneous small vessel vasculitis are randomized to 3 different treatment groups and monitored for response.

• A PHASE 2, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, MULTICENTER STUDY TO EVALUATE THE CLINICAL EFFECT, PHARMACODYNAMIC, PHARMACOKINETIC AND SAFETY PROFILE OF PF-06823859 IN ADULT PARTICIPANTS WITH ACTIVE CLE OR SLE WITH CUTANEOUS MANIFESTATIONS, Pfizer
• Phase 1b/2, double-blind, placebo-controlled, randomized, parallel-arm study to explore the safety, pharmacokinetics, and proof of biological activity of DS-7011a in patients with systemic lupus erythematosus and active cutaneous lupus erythematosus, Daiichi Sankyo, Inc.
• Phase I/II study of dabrafenib, trametinib, and navitoclax in BRAF mutant melanoma (Phase I and II) and other solid tumors (Phase I only)., National Cancer Institute, Co-PI

• Seger, E., W, Tarantino, I., S, Neill, B., C, Wang, T. 2020. Successful non-operative treatment of eruptive keratoacanthomas refractory to excision.. Dermatology online journal, 26 (3)
• Seger, E., W, Tarantino, I., S, Neill, B., C, Wang, T. 2020. Relative Efficacy of Nonoperative Treatment of Keratoacanthomas.. Journal of cutaneous medicine and surgery, 24 (1), 41-46. https://journals.sagepub.com/doi/full/10.1177/1203475419882336?url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&rfr_dat=cr_pub%3Dpubmed
• Blaise, B, Ryser, T, Fraga, G., R, Wang, T. 2019. Coalescing papules on bilateral mastectomy scars.. Cutis, 103 (4), E30-E32
• Liu, D, Wu, D., J, Rajpara, A, Wang, T, Aires, D., J. 2019. Clobetasol pretreatment to reduce and prevent injection site dermatitis from biologic agents.. Journal of the American Academy of Dermatology, 80 (4), e71
• Siscos, S., M, Downing, M, Rajpara, A, Liu, D, Wang, T, Aires, D., J. 2019. Silicone gel sheeting for continuous positive airway pressure irritation in adults.. Journal of the American Academy of Dermatology. https://www.ncbi.nlm.nih.gov/pubmed/?term=Silicone+gel+sheeting+for+continuous+positive+airway+pressure+irritation+in+adults.
• Liu, D., Y, Gul, M., I, Wick, J, Rajpara, A., N, Isedeh, P, Wang, T, Aires, D., J. 2019. Long-term sheltering mustaches reduce incidence of lower lip actinic keratosis.. Journal of the American Academy of Dermatology, 80 (6), 1757-1758.e1. https://www.ncbi.nlm.nih.gov/pubmed/?term=Long-term+sheltering+mustaches+reduce+incidence+of+lower+lip+actinic+keratosis.
• Rickstrew, J, Wang, T, Liu, D, Rajpara, A, Aires, D., J. 2017. Mitigation or prevention of mild hair dye contact dermatitis after pretreatment with clobetasol foam.. Journal of the American Academy of Dermatology, 77 (5), e129
• 2014. Skin cancer in the immunocompromised. In Skin Diseases in the Immunocompromised
• 2017. Chapter 32: Melanoma